Meizhong Xu

A Novel Kinase Inhibitor, INCB28060, Blocks c-MET–Dependent Signaling, Neoplastic Activities, and Cross-Talk with EGFR and HER-3

Xiangdong Liu, Qian Wang, Gengjie Yang et al. · Clinical Cancer Research · 2011 · 274 citations

Medicine, Oncology, Pharmacology +16

Identification of ADAM10 as a major source of HER2 ectodomain sheddase activity in HER2 overexpressing breast cancer cells

Phillip C.C. Liu, Xiangdong Liu, Yanlong Li et al. · Cancer Biology & Therapy · 2006 · 186 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Photochemically enhanced binding of small molecules to the tumor necrosis factor receptor-1 inhibits the binding of TNF-α

Percy H. Carter, Peggy Scherle, Jodi A. Muckelbauer et al. · Proceedings of the National Academy of Sciences · 2001 · 140 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +16

Discovery of Pemigatinib: A Potent and Selective Fibroblast Growth Factor Receptor (FGFR) Inhibitor

Liangxing Wu, Colin Zhang, Chunhong He et al. · Journal of Medicinal Chemistry · 2021 · 74 citations · Full text

Medicine, Oncology, Pharmacology +16

Both 5-arylidene-2-thioxodihydropyrimidine-4,6(1H,5H)-diones and 3-thioxo-2,3-dihydro-1H-imidazo[1,5-a]indol-1-ones are light-Dependent tumor necrosis factor-α antagonists

Matthew E. Voss, Percy H. Carter, Andrew J. Tebben et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 70 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +7